UC San Diego Health System in partnership with the U.S. Hereditary Angioedema Association (HAEA), a non-profit patient advocacy organization, has opened the nation’s first dedicated center for diagnosing and treating diverse forms of swelling, known collectively as angioedema.
High blood pressure and nonalcoholic fatty liver disease (NAFLD) are two emerging health problems related to the epidemic of childhood obesity. In a recent study, researchers at University of California, San Diego School of Medicine sought to determine the prevalence of high blood pressure in children with NAFLD, which places them at risk for premature cardiovascular disease.
People with moderate to severe obstructive sleep apnea may have an intrinsic inability to burn high amounts of oxygen during strenuous aerobic exercise according to a new study led by researchers at University of California, San Diego School of Medicine.
UC San Diego Health System is a world leader in chronic thromboembolic pulmonary hypertension (CTEPH), and now with a $7.6 million grant, has helped launch the first national CTEPH registry to improve best practices and patient care.
While investigating a rare genetic disorder, researchers at the University of California, San Diego School of Medicine have discovered that a ubiquitous signaling molecule is crucial to cellular reprogramming, a finding with significant implications for stem cell-based regenerative medicine, wound repair therapies and potential cancer treatments.
Researchers at the University of California, San Diego School of Medicine and Ludwig Cancer Research, with colleagues across the country and world, have discovered that a significant number of mouse genes do not in fact behave like their human counterparts, suggesting science will need to rethink at least some roles of the lab mouse as a model organism.
The San Diego Union-Tribune, March 16
The San Diego Union-Tribune, March 10
KFMB, February 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
